Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

Dr Mario Sznol - Yale Cancer Center New Haven, USA
Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma ( Dr Mario Sznol - Yale Cancer Center New Haven, USA )
1 Jun 2013

Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

Dr Andreas du Bois - Kliniken Essen Mitte, Germany
Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer ( Dr Andreas du Bois - Kliniken Essen Mitte, Germany )
1 Jun 2013

Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2013

Overview of the EurocanPlatform

Prof Gordon McVie – ecancer and IEO, Milan, Italy
Overview of the EurocanPlatform ( Prof Gordon McVie – ecancer and IEO, Milan, Italy )
30 May 2013

Landmark cooperative projects in Portugal

Dr Jose Laranja Pontes – Instituto Porugues de Oncologia do Porto Fransisco Gentil, Portugal
Landmark cooperative projects in Portugal ( Dr Jose Laranja Pontes – Instituto Porugues de Oncologia do Porto Fransisco Gentil, Portugal )
30 May 2013

Excellence in comprehensive cancer care

Dr Wim van Harten – Netherlands Kanker Insitut, Amsterdam, The Netherlands
Excellence in comprehensive cancer care ( Dr Wim van Harten – Netherlands Kanker Insitut, Amsterdam, The Netherlands )
30 May 2013

Manchester Cancer Services

Dr Chris Harrison – Christie Hospital NHS Foundation Trust, Manchester, UK
Manchester Cancer Services ( Dr Chris Harrison – Christie Hospital NHS Foundation Trust, Manchester, UK )
30 May 2013

Establishment of the EurocanPlatform

Dr Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden
Establishment of the EurocanPlatform ( Dr Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden )
30 May 2013

Evolution of the EurocanPlatform

Prof Julio Celis – Danish Cancer Society, Institute of Cancer Biology, Copenhagen, Denmark
Evolution of the EurocanPlatform ( Prof Julio Celis – Danish Cancer Society, Institute of Cancer Biology, Copenhagen, Denmark )
30 May 2013

Institute Jules Bordet and the OECI

Dr Dominique De Valeriola – Institute Jules Bordet, Brussels, Belgium
Institute Jules Bordet and the OECI ( Dr Dominique De Valeriola – Institute Jules Bordet, Brussels, Belgium )
30 May 2013

Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours

Dr Matthew Murray - Cambridge Cancer Centre, UK
Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours ( Dr Matthew Murray - Cambridge Cancer Centre, UK )
29 May 2013

Epidemiology of central nervous system germ cell tumours

Dr Eric Bouffet - The Hospital for Sick Children, Ontario, Canada
Epidemiology of central nervous system germ cell tumours ( Dr Eric Bouffet - The Hospital for Sick Children, Ontario, Canada )
29 May 2013